Singh, D.K. and Mondal, A. and Shiras, A. (2018) Challenges in glioblastoma biology and implications in personalized therapy. International. Journal of Neuro-oncology, 1 (1). pp. 17-24.

Full text not available from this repository. (Request a copy)

Abstract

Glioblastoma is one of the most dreaded tumors of the central nervous system. The tumors show poor prognosis with patients showing a median survival of only 12–15 months despite all the treatment regimens. Recent studies have contributed a lot to our understanding of the pathogenesis of this disease and have suggested the presence of glioma stem cell (GSC) population as drivers of tumor growth. The GSCs are also considered responsible for tumor recurrence leading to treatment failure. It is thus increasingly becoming important to understand the biology of this tumor and effectively classify these tumors based on genetic mutations. Advancement in diagnosis to uncover the stages of tumor development and customize treatment modalities would increase chances for better responsiveness to various treatments and help us witness positive outcomes. These altogether could help in improving the survival of patients and their quality of life. An urgent need to find better ways of diagnosis could be achieved by combining our knowledge of basic science with advanced technologies. This review summarizes the past and present status of glioma biology, their classification and pathogenesis. It highlights the current pitfalls in clinical treatment and recent advances in diagnostics which could have clinical implications in near future.

Item Type:	Article
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	19 Feb 2020 09:51
Last Modified:	19 Feb 2020 09:51
URI:	http://nccs.sciencecentral.in/id/eprint/682

Actions (login required)

View Item